Injectable Myocardial Matrix Hydrogel Mitigates Negative Left Ventricular Remodeling in a Chronic Myocardial Infarction Model
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 6 (4) , 350-361
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Heart, Lung, and Blood Institute
This publication has 50 references indexed in Scilit:
- Cardiac Metabolism in Heart FailureCirculation Research, 2013
- Pathview: an R/Bioconductor package for pathway-based data integration and visualizationBioinformatics, 2013
- Function and fate of myofibroblasts after myocardial infarctionFibrogenesis & Tissue Repair, 2013
- Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in ratsJournal of Translational Medicine, 2013
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Catheter-Deliverable Hydrogel Derived From Decellularized Ventricular Extracellular Matrix Increases Endogenous Cardiomyocytes and Preserves Cardiac Function Post-Myocardial InfarctionJACC, 2012
- Transforming growth factor (TGF)-β signaling in cardiac remodelingJournal of Molecular and Cellular Cardiology, 2011
- Biomaterial strategies for alleviation of myocardial infarctionJournal of The Royal Society Interface, 2011
- Design and Characterization of an Injectable Pericardial Matrix Gel: A Potentially Autologous Scaffold for Cardiac Tissue EngineeringTissue Engineering Part A, 2010
- Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineeringBiomaterials, 2009